4502.T
Takeda Pharmaceutical Company Limited
プライム · 医薬品 · 医薬品 · JP
JPY 5,908.00
+1.44%Year over year
Reported trailing growth
- Revenue
- -1.7%
- EBITDA
- —
- EBIT
- +19.3%
- EPS
- +77.6%
- Free cash flow
- +1.1%
- Operating cash flow
- -1.5%
Forward estimates
Based on analyst estimates
- Revenue
- +0.5%
- EBITDA
- —
- EPS
- -20.1%
Three-year CAGR
- Revenue
- +3.8%
- EBITDA
- -0.7%
- EBIT
- -5.9%
- Net income
- -15.4%
- EPS
- -15.8%
- Free cash flow
- +1.1%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Mar 1, 2026